Integrated BioPharma (INBP) Stock Chart & Stock Price History $0.28 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Integrated BioPharma Stock Price Performance The Integrated BioPharma (INBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 47.37%, with a year-to-date return of -15.07%. In the past month, the stock has decreased 18.22%, reflecting recent market activity. As of the latest close, Integrated BioPharma traded at $0.28 with a market cap of $8.67 million and volume of 5,200 shares. Five years ago, the stock traded at $0.44, representing a 36.36% decrease over that period. At the time, it had a market cap of $13.02 million and a volume of 0 shares. Receive INBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.14%1 Month Performance-18.22%3 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year PerformanceN/A5 Year PerformanceN/A INBP Stock Chart for Sunday, August, 10, 2025 INBP Chart by TradingView Integrated BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$0.28$0.28$0.28$0.275,200 shs$8.67 million08/07/2025$0.27$0.28+3.70%$0.28$0.275,200 shs$8.67 million08/06/2025$0.28$0.27-3.71%$0.28$0.2745,629 shs$8.37 million08/05/2025$0.28$0.28-0.99%$0.29$0.281,197 shs$8.69 million08/04/2025$0.28$0.28-0.21%$0.28$0.287,600 shs$8.77 million08/01/2025$0.29$0.28-0.63%$0.28$0.282,500 shs$8.79 million07/31/2025$0.29$0.29$0.29$0.2931,609 shs$8.85 million07/30/2025$0.29$0.29-1.38%$0.29$0.2931,609 shs$8.85 million07/29/2025$0.29$0.29+0.49%$0.29$0.2944,588 shs$8.97 million07/28/2025$0.29$0.29+1.03%$0.29$0.296,972 shs$8.93 million Get the Latest News and Ratings for INBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$0.29$0.29$0.29$0.2811,600 shs$8.84 million07/24/2025$0.29$0.29$0.29$0.2811,600 shs$8.84 million07/23/2025$0.28$0.29+0.81%$0.29$0.2811,600 shs$8.84 million07/22/2025$0.31$0.28-8.71%$0.29$0.2814,675 shs$8.77 million07/21/2025$0.31$0.31$0.31$0.309,400 shs$9.60 million07/18/2025$0.32$0.31-2.79%$0.31$0.309,400 shs$9.60 million07/17/2025$0.32$0.32+1.24%$0.32$0.322,096 shs$9.88 million07/16/2025$0.31$0.32+1.61%$0.32$0.322,500 shs$9.76 million07/15/2025$0.32$0.31-3.13%$0.33$0.2829,900 shs$9.60 million07/14/2025$0.34$0.32-5.88%$0.33$0.309,600 shs$9.91 million07/11/2025$0.34$0.34-0.70%$0.34$0.313,000 shs$10.53 million07/10/2025$0.34$0.34$0.34$0.333,120 shs$10.61 million07/09/2025$0.36$0.34-3.89%$0.34$0.333,120 shs$10.61 million Related Companies ENLV Stock Chart SLGL Stock Chart MRSN Stock Chart RANI Stock Chart XLO Stock Chart MDCX Stock Chart AKTX Stock Chart KPTI Stock Chart CLSD Stock Chart DYAI Stock Chart Receive INBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:INBP) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integrated BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
